Skip to main content
. 2019 May 15;10(5):269–279. doi: 10.4239/wjd.v10.i5.269

Table 2.

Summary of non-proteinuric diabetic nephropathy literature

Field Summary of non-proteinuric diabetic nephropathy literature
Prevalence 57% of diabetic nephropathy patients
Pathogenesis Vascular and soluble elements, such as uric acid, TNFα, and VEGF, affecting renal microhemodynamics
Diagnosis (1) Increased renal resistive index; (2) Alterations in TNFα, TGF-β, endothelin, and other interleukins
Treatment (1) Enalapril; (2) Losartan; (3) Heparin; (4) Pentoxifylline

TNFα: Tumor necrosis factor alpha; VEGF: Vascular endothelial growth factor; TGF: Transforming growth factor.